EE200100096A - Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina - Google Patents

Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina

Info

Publication number
EE200100096A
EE200100096A EEP200100096A EEP200100096A EE200100096A EE 200100096 A EE200100096 A EE 200100096A EE P200100096 A EEP200100096 A EE P200100096A EE P200100096 A EEP200100096 A EE P200100096A EE 200100096 A EE200100096 A EE 200100096A
Authority
EE
Estonia
Prior art keywords
azacyclic
medicament
pharmaceutical composition
composition containing
cyclic compound
Prior art date
Application number
EEP200100096A
Other languages
English (en)
Estonian (et)
Inventor
Grewal Gurmit
Toy-Palmer Anna
Cai Xiong
Mark Latham George
Original Assignee
Ucb, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb, S.A. filed Critical Ucb, S.A.
Publication of EE200100096A publication Critical patent/EE200100096A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
EEP200100096A 1998-08-18 1999-08-16 Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina EE200100096A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
EE200100096A true EE200100096A (et) 2002-06-17

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100096A EE200100096A (et) 1998-08-18 1999-08-16 Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina

Country Status (30)

Country Link
US (5) US6093724A (de)
EP (1) EP1112272B1 (de)
JP (1) JP2002523416A (de)
KR (1) KR20010072784A (de)
CN (1) CN1312812A (de)
AR (1) AR020199A1 (de)
AT (1) ATE227724T1 (de)
AU (1) AU750566B2 (de)
BG (1) BG105256A (de)
BR (1) BR9913072A (de)
CA (1) CA2340946A1 (de)
CO (1) CO5130018A1 (de)
DE (1) DE69903961T2 (de)
EE (1) EE200100096A (de)
ES (1) ES2191455T3 (de)
HK (1) HK1038918A1 (de)
HU (1) HUP0103203A3 (de)
ID (1) ID27544A (de)
IL (1) IL141050A0 (de)
IS (1) IS5827A (de)
NO (1) NO20010804L (de)
NZ (1) NZ509762A (de)
PE (1) PE20000988A1 (de)
PL (1) PL346247A1 (de)
RU (1) RU2219179C2 (de)
SK (1) SK1892001A3 (de)
TR (1) TR200100462T2 (de)
WO (1) WO2000011001A1 (de)
YU (1) YU13301A (de)
ZA (1) ZA200100978B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20031013A3 (en) * 2000-10-19 2004-03-17 Pfizer Products Inc. Bridged piperazine derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
MX2009010175A (es) * 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
EP2497771A1 (de) * 2007-03-23 2012-09-12 Abbott Laboratories 4-substituierte Azaadamantan-Derivate und Verfahren zu ihrer Verwendung
WO2010145208A1 (en) * 2009-06-19 2010-12-23 Abbott Laboratories Diazahomoadamantane derivatives and methods of use thereof
ES2742728T3 (es) 2009-07-22 2020-02-17 PureTech Health LLC Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP2560488B1 (de) 2010-04-23 2015-10-28 Cytokinetics, Inc. Bestimmte aminopyrimidine und aminotriazine, zusammensetzungen daraus und verfahren zu ihrer verwendung
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2619205B1 (de) * 2010-09-23 2017-05-17 AbbVie Bahamas Ltd. Monohydrat eines azaadamantanderivates
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
EP3651762B1 (de) 2017-07-12 2024-07-03 Vanderbilt University Antagonisten des muskarinischen acetylcholinrezeptors m4
JP7270989B2 (ja) 2017-10-20 2023-05-11 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体m4のアンタゴニスト
EP3732163A4 (de) * 2017-12-20 2021-07-14 Vanderbilt University Antagonisten des muskarinischen acetylcholinrezeptors m4
PT3856182T (pt) 2018-09-28 2026-03-10 Karuna Therapeutics Inc Composições e métodos para o tratamento de perturbações melhoradas pela ativação dos recetores muscarínicos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク シヤープ エンド ドーム リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
TR199800780T2 (xx) * 1995-11-02 1998-07-21 Neurosearch A/S Kayna�m�� tropan t�revleri, haz�rlan��lar� ve kullan�mlar�.
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
BG105256A (en) 2001-11-30
CO5130018A1 (es) 2002-02-27
BR9913072A (pt) 2001-05-15
TR200100462T2 (tr) 2001-09-21
US6323194B1 (en) 2001-11-27
US6251916B1 (en) 2001-06-26
HK1038918A1 (zh) 2002-04-04
ZA200100978B (en) 2002-02-05
PE20000988A1 (es) 2000-09-30
KR20010072784A (ko) 2001-07-31
EP1112272B1 (de) 2002-11-13
ES2191455T3 (es) 2003-09-01
DE69903961T2 (de) 2003-07-03
WO2000011001A1 (en) 2000-03-02
US20020045617A1 (en) 2002-04-18
NZ509762A (en) 2002-12-20
SK1892001A3 (en) 2001-11-06
DE69903961D1 (de) 2002-12-19
IS5827A (is) 2001-01-26
ID27544A (id) 2001-04-12
RU2219179C2 (ru) 2003-12-20
US6555550B1 (en) 2003-04-29
JP2002523416A (ja) 2002-07-30
US6093724A (en) 2000-07-25
AR020199A1 (es) 2002-05-02
NO20010804L (no) 2001-04-11
YU13301A (sh) 2005-06-10
EP1112272A1 (de) 2001-07-04
HUP0103203A3 (en) 2002-10-28
IL141050A0 (en) 2002-02-10
NO20010804D0 (no) 2001-02-16
US6423842B1 (en) 2002-07-23
CN1312812A (zh) 2001-09-12
HUP0103203A2 (hu) 2002-01-28
AU750566B2 (en) 2002-07-25
ATE227724T1 (de) 2002-11-15
CA2340946A1 (en) 2000-03-02
PL346247A1 (en) 2002-01-28
AU5775899A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
IL144910A0 (en) Cyclic compounds and pharmaceutical compositions containing the same
IL142531A0 (en) Cyclic peptide compound, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0204071A3 (en) Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use
BR0014526B1 (pt) compostos cíclicos de seis elementos contendo nitrogênio aromático, composição farmacêutica e uso do mesmo
HUP0300203A3 (en) Novel cyclic amide derivatives, and pharmaceutical compositions containing same
HUP0103265A3 (en) Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
FI991485A0 (fi) Uusi farmaseuttinen koostumus
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
DK1052974T3 (da) Farmaceutisk sammensætning indeholdende epothilon
IL158168A0 (en) 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same
HUP0100950A3 (en) Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP0102676A3 (en) Solid, quick dissolving pharmaceutical compositions containing cetrizine
EE200000482A (et) Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200000483A (et) Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
EE200300488A (et) Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
HUP0401733A3 (en) Cyclic amine-derivatives and pharmaceutical compositions containing them
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
EE200200109A (et) Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim
EE200300398A (et) Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
EE05406B1 (et) Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon
HUP0201696A3 (en) Cyclic peptides, pharmaceutical compositions comprising thereof and their use
IL150904A0 (en) Cyclic hexapeptide derivatives and pharmaceutical compositions containing the same